Many women with cancer want advice for managing sexual function issues, and clinicians are tuning in, new studies suggest. Decreased sexual function is a side effect […]

TOPLINE: Treatment with palliative “Quad Shot” radiotherapy with concurrent immunotherapy appears safe and significantly improves local control in symptomatic patients with recurrent and metastatic head and […]

TOPLINE: Despite concerns about malpractice risk among physicians, investigators found no successful malpractice litigation related to active surveillance as a management strategy for low-risk cancers. METHODOLOGY: […]

TOPLINE:  “Optimizing vaccination status should be considered a key element in the care of patients with cancer,” according to the authors of newly released American of […]

Minimally invasive cytoreductive surgery for epithelial ovarian cancer appears to be safe and does not compromise survival, compared with open surgery, when patients have completely resected […]

A French prospective real-life cohort confirmed the favorable prognosis of nonmetastatic microsatellite instability (MSI) colorectal cancers. These cancers nevertheless entailed a high risk for recurrence in […]

Combining the bispecific antibody amivantamab (Rybrevant) with chemotherapy in the first- or second-line setting offers ongoing benefit to patients with epidermal growth factor receptor (EGFR)–mutated advanced […]

The investigational bispecific T-cell engager tarlatamab achieved durable responses and clinically meaningful survival outcomes in patients with small-cell lung cancer (SCLC), particularly at lower doses, according […]

(Reuters) -Novocure’s therapy met the main goal of a late-stage trial of slowing the progression of cancer to the brain in patients with a type of […]